Category: Biography

Anuja Agarwala, Medicine, Best Innovator Award

Posted on by scizentox scizentoxLeave a Comment on Anuja Agarwala, Medicine, Best Innovator Award

Miss. Anuja Agarwala: Former Senior Dietitian (Pediatrics) at AIIMS, India

1. Article Details

This is a commentary on a primary study (Rohtagi et al.) interpreting its clinical relevance.

2. Novelty

  • Introduces phase angle (PhA) as a functional biomarker rather than just structural (weight-based) assessment.
  • Shifts focus from “weight gain” to “internal cellular recovery.”
  • Highlights use of bioelectrical impedance in pediatric SAM—a relatively underutilized approach in low-resource settings.

The novelty lies in applying a cellular-level recovery indicator in SAM management.

3. Impact

Clinical Impact:

  • Early detection of incomplete recovery.
  • Identification of children at risk of relapse after discharge.

Public Health Impact:

  • Relevant for countries with high SAM burden (e.g., India).
  • May refine discharge criteria from nutrition rehabilitation centers.

Policy Impact:

  • Suggests need to redefine recovery beyond anthropometric measures.

Overall, it has moderate to high potential impact if validated further.

4. Originality

  • The commentary is interpretative, not experimental.
  • Originality lies in synthesizing evidence and contextualizing PhA in SAM care pathways.
  • The primary study (Rohtagi et al.) provides the experimental originality, while this article strengthens the conceptual framing.

5. Experimental Rigor

  • Strengths highlighted:
    • Correlation of PhA with WHZ, body cell mass, and intracellular water.
    • Longitudinal tracking during hospitalization and follow-up.
  • Limitations noted:
    • Small sample size, especially for edematous children.
    • Limited measurement time points.
    • Lack of pediatric reference standards for PhA.

The author critically appraises methodology, indicating balanced scientific rigor.

6. Sustainability Impact

Healthcare Sustainability:

  • Promotes better-targeted interventions, potentially reducing relapse and re-hospitalization.

Resource Optimization:

  • Avoids over-reliance on weight-based discharge criteria.
  • Encourages smarter follow-up care.

Challenges:

  • Requires devices (bioelectrical impedance analyzers) and trained personnel.

Sustainable initially in referral centers; less feasible immediately at the community level.

7. Applicability

High Applicability:

  • Tertiary hospitals and nutrition rehabilitation centers.

Moderate Applicability:

  • District hospitals with equipment availability.

Low Applicability:

  • Rural/community settings due to cost and logistics constraints.

Practical suggestion: phased implementation as devices become more affordable.

8. Overall Critical Insight

The article emphasizes a paradigm shift: recovery from SAM is more than weight gain. True recovery includes:

  • Cellular integrity
  • Fluid balance
  • Functional health

Research Portfolio

Anuja Agarwala is a highly accomplished pediatric and genetic metabolic nutrition expert with over 30 years of clinical, academic, and policy experience at All India Institute of Medical Sciences. She has been instrumental in establishing pediatric nutrition as a specialized clinical discipline in India, particularly in managing complex conditions such as inborn errors of metabolism, pediatric epilepsy, and chronic childhood diseases. Her career reflects a unique integration of patient care, translational research, and national health policy contributions.

Online Profile

Scopus Profile

She maintains a strong professional presence through her affiliations with leading global and national organizations, including Genetic Metabolic Dietitians International and Society for the Study of Inborn Errors of Metabolism, where she contributes to research, education, and international collaborations. In India, she serves as an expert advisor to Food Safety and Standards Authority of India, shaping regulatory frameworks, nutrition policies, and standards for specialized medical nutrition products.

Her academic visibility is reflected through indexed research databases, where her Scopus profile reports over 690 citations across more than 20 publications, with an h-index of 13, indicating consistent research impact. She is also registered with ORCID for global research identification and is actively engaged with international organizations such as Genetic Metabolic Dietitians International and Society for the Study of Inborn Errors of Metabolism, strengthening her global academic and professional presence.

Education

Her educational background includes a Bachelor’s degree in Home Science and a Postgraduate Diploma in Dietetics and Public Health Nutrition from the University of Delhi, followed by a Master’s degree in Institutional Food Administration and Dietetics from Maharaja Sayajirao University, Baroda. She has pursued extensive continuing education through international certifications in metabolic dietetics, public health nutrition, ketogenic diet therapy, and nutrigenomics, reflecting her commitment to lifelong learning and specialization.

Research Focus

Her research interests center on pediatric nutrition interventions in complex medical conditions, including inborn errors of metabolism (IEM), drug-resistant epilepsy, type 1 diabetes mellitus, and gastrointestinal disorders like celiac disease. She is particularly focused on developing culturally appropriate, evidence-based dietary therapies tailored to Indian populations, as well as advancing clinical nutrition as a critical component of multidisciplinary pediatric care.

Experience

During her tenure as Senior Dietician at AIIMS from 1988 to 2022, she developed and led specialized pediatric nutrition services, including outpatient clinics that manage thousands of patients annually. Her experience spans multiple pediatric subspecialties such as neonatology, gastroenterology, endocrinology, nephrology, and critical care, and she has played a key role in training medical students, dietitians, and healthcare professionals across India.

Research Timeline & Activities

Over the course of her career, she has contributed to more than 40 peer-reviewed publications and participated in over 20 research projects funded by national and international agencies such as WHO and ICMR. Her work includes randomized controlled trials, development of diagnostic innovations, and collaborative research in rare diseases, along with mentoring postgraduate research, reviewing scientific manuscripts, and contributing to academic and clinical guidelines.

Awards & Honors

She has been recognized with several prestigious awards, including the RND Sadhana Award (2022) for excellence in clinical nutrition and an international Best Nutritionist Award in 2023. She has also been honored as a Woman Leader in Nutrition, acknowledging her leadership, innovation, and long-standing contributions to pediatric healthcare and nutrition science.

Strengths for the Best Innovator Award based:

1. Pioneering Clinical Innovation
Introduced phase angle (PhA) as a complementary biomarker for pediatric SAM recovery, moving beyond conventional weight-based metrics.
Demonstrated the practical use of bioelectrical impedance in assessing cellular-level recovery in malnourished children.
Emphasized individualized, physiology-based care rather than one-size-fits-all approaches.
2. Research and Evidence-Based Impact
Synthesized and applied cutting-edge research linking PhA, body cell mass, and intracellular hydration to nutritional recovery.
Advocated for longitudinal monitoring, highlighting early detection of children at risk of relapse.
Her work integrates clinical insight with evidence-based metrics, bridging research and patient care.
3. Educational Leadership and Knowledge Translation
Trained and mentored generations of medical students, dietitians, and healthcare professionals in specialized pediatric nutrition and metabolic disorders.
Developed educational frameworks for translating complex research findings into practical clinical protocols.
Played a key role in capacity-building in pediatric nutrition across India.
4. Policy Influence and Sustainability
Contributed as an expert advisor to the Food Safety and Standards Authority of India, shaping nutrition policies and standards for medical nutrition products.
Advocated for sustainable interventions that optimize resources, reduce relapse rates, and improve long-term pediatric outcomes.
Emphasized phased and scalable implementation of innovative diagnostic tools like PhA in low-resource settings.
5. Global Recognition and Professional Leadership
Active contributor to international organizations including Genetic Metabolic Dietitians International and Society for the Study of Inborn Errors of Metabolism.
Maintains a strong research presence with over 690 citations, an h-index of 13, and multiple peer-reviewed publications.
Recognized with awards such as the RND Sadhana Award (2022) and Best Nutritionist Award (2023), reflecting leadership, innovation, and excellence in clinical nutrition.

Shubhamoy Gantait, Medicine, Emerging Researcher Award

Posted on by scizentox scizentoxLeave a Comment on Shubhamoy Gantait, Medicine, Emerging Researcher Award

Dr. Shubhamoy Gantait: FNB neurovascular intervention fellow at Mazumdar Shaw Medical centre, Narayana Health, India.

Article Details

Novelty

  • This study is among the first to correlate dual-energy CT quantitative parameters with IHC biomarkers in invasive breast cancer.

  • Introduces the concept of using DECT, traditionally for anatomical imaging, as a functional imaging tool reflecting tumor vascularity and biology.

  • Offers non-invasive insight into ER/PR/HER2 status, potentially reducing dependency on tissue biopsy in certain scenarios.

Impact

  • Can influence clinical decision-making by predicting tumor receptor status before biopsy results are available.

  • May help tailor neoadjuvant therapies more quickly, especially in aggressive or HER2-positive cancers.

  • Adds value to imaging studies by integrating anatomical and functional biomarkers in a single DECT scan.

Originality

  • Combines quantitative DECT parameters (IC, NIC, Zeff, slope K) with IHC biomarker analysis, which is not commonly reported in prior breast cancer studies.

  • Uses novel parameter slope K to correlate with tumor receptor expression.

  • Applies DECT as a dual diagnostic tool: staging and functional characterization.

Experimental Rigor

  • Prospective design increases reliability of results.

  • Multiple DECT parameters were systematically measured with region-of-interest (ROI) methodology, enhancing reproducibility.

  • Appropriate statistical methods (ROC curves, p-values) were applied.

  • Limitation: The study does not mention the sample size, which could affect statistical power.

Sustainability Impact

  • Offers a non-invasive imaging approach, potentially reducing repeat biopsies and associated medical waste.

  • Could decrease resource use in pathology labs if predictive imaging becomes reliable.

  • Enhances efficient patient workflow in oncology care settings, contributing indirectly to healthcare sustainability.

Applicability

  • Clinically applicable in breast cancer centers equipped with DECT scanners.

  • Can complement existing diagnostic protocols for ER/PR/HER2 status determination.

  • May guide personalized treatment decisions, especially in cases where biopsy is risky or delayed.

  • Potential for integration into AI-assisted imaging platforms for automated IHC prediction.

Research Portfolio

Dr. Shubhamoy Gantait is a highly skilled neurovascular interventionist and radiologist with advanced expertise in both diagnostic and interventional imaging. Currently serving as an FNB fellow at Mazumdar Shaw Medical Centre, Narayana Health, Bangalore, he specializes in stroke interventions, peripheral vascular procedures, and image-guided non-vascular interventions. With a strong foundation in neuroimaging, he combines clinical precision with research-driven approaches to improve patient outcomes.

Online Profile

ORCID Profile

Dr. Gantait maintains a professional presence across institutional and international platforms, reflecting his active engagement in the global radiology community. He is a member of prestigious organizations including the National Academy of Medical Sciences (MNAMS), Royal College of Radiology (RCR), Indian Society of Vascular Interventional Radiology (ISVIR), and Cardiovascular and Interventional Radiological Society of Europe (CIRSE). These affiliations underscore his commitment to advancing interventional radiology standards and sharing expertise across networks.

Education

Dr. Gantait earned his DM in Neuroimaging and Interventions from JIPMER, Puducherry, and completed a DNB in Radiodiagnosis from Rajiv Gandhi Cancer Institute, New Delhi. He graduated with an MBBS degree from Calcutta National Medical College, achieving honors in pediatrics and preventive & social medicine. His ongoing FNB fellowship in Neurovascular Interventions at Mazumdar Shaw Medical Centre further strengthens his super-specialty knowledge and procedural expertise in complex cerebrovascular and peripheral interventions.

Research Focus

His research primarily focuses on advanced neuroimaging techniques and image-guided interventions aimed at improving diagnostic accuracy and therapeutic outcomes. Dr. Gantait has investigated the role of ASL perfusion MRI in acute encephalopathy and diffusion-weighted MRI in prostate cancer evaluation, demonstrating a commitment to integrating imaging biomarkers into clinical decision-making. His work bridges diagnostic radiology and interventional strategies, contributing to innovations in stroke and vascular care.

Experience

Dr. Gantait has a diverse clinical background, having worked in top-tier medical institutions including JIPMER, Rajiv Gandhi Cancer Institute, BP Poddar Hospital, and Welkin Medicare. He has extensive experience in CT, MRI, ultrasound, and fluoroscopic procedures, and is proficient in advanced neurovascular interventions, peripheral vascular embolizations, biliary procedures, and sclerotherapy of vascular malformations. His roles have ranged from senior resident and consultant radiologist to interventional fellow, demonstrating a blend of academic rigor and hands-on expertise.

Research Timeline & Activities

Dr. Gantait began his research journey during his DNB residency (2015–2018), focusing on diffusion-weighted MRI in oncology. During his DM training (2021–2023), he conducted studies on ASL perfusion MRI in acute neurological disorders, developing clinical protocols for neurovascular assessment. Currently, as an FNB fellow, he participates in multicenter clinical trials, protocol development for stroke interventions, and advanced imaging studies, actively contributing to research in neurovascular and peripheral interventions.

Awards & Honors

He has been recognized with multiple accolades for academic excellence and clinical proficiency, including the Best DNB Resident Award (2017), gold medal in pediatrics during MBBS, 1st rank in FET 2023 in Neurovascular Intervention, and 3rd rank in JIPMER DM/MCh entrance (2021). Early academic achievements include a state-level merit ranking in Class 10 and MBBS honors in preventive medicine and pediatrics, reflecting a consistent record of excellence.

Strength an Emerging Researcher Award 

1. Early-Career Status

Requirement: Typically researchers with under 5–7 years of post-doctoral or equivalent experience.

Assessment: Dr. Gantait completed his DNB (2018) and DM (2023) and is currently pursuing an FNB fellowship. His active post-specialty research career spans roughly 3–5 years.

Verdict:  Meets the early-career criterion.

2. Research Innovation & Originality

Evidence:

First studies correlating dual-energy CT quantitative parameters with IHC biomarkers in breast cancer, integrating anatomical and functional imaging.

Novel use of slope K parameter for predicting tumor receptor expression.

Pioneering research in ASL perfusion MRI for acute encephalopathy and diffusion-weighted MRI in oncology.

Impact: Introduces non-invasive predictive imaging approaches with clinical decision-making potential.

Verdict:  Strong innovation and originality.

3. Research Impact & Applicability

Evidence:

DECT study offers potential to reduce biopsy dependency, accelerate neoadjuvant therapy decisions, and enhance imaging efficiency.

Work on neuroimaging (stroke, peripheral vascular interventions) demonstrates translational value for patient care.

Publications in reputed journals and involvement in multicenter clinical trials.

Verdict:  High translational and clinical impact.

4. Academic & Professional Recognition

Evidence:

Membership in MNAMS, RCR, ISVIR, CIRSE, reflecting international recognition.

Multiple awards: Best DNB Resident, Gold Medal in MBBS Pediatrics, 1st rank FET 2023, 3rd rank JIPMER DM/MCh entrance.

Verdict: Recognized by peers and professional bodies; strong leadership potential.

5. Sustained Research Trajectory

Evidence:

Continuous research from DNB residency (2015–2018) → DM (2021–2023) → current FNB fellowship.

Active in clinical trials, imaging protocol development, and interdisciplinary collaborations.

Demonstrates a trajectory from foundational MRI research to innovative DECT imaging in oncology.

Verdict: Demonstrates a strong, sustained and evolving research trajectory.